{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T03:06:31Z","timestamp":1776567991972,"version":"3.51.2"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100013220","name":"Ultragenyx Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013220","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s00198-021-05875-w","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T15:02:51Z","timestamp":1614956571000},"page":"1825-1836","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Clinical and molecular characterization of Chilean patients with X-linked hypophosphatemia"],"prefix":"10.1007","volume":"32","author":[{"given":"M.","family":"Jim\u00e9nez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Ivanovic-Zuvic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Loureiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.A.","family":"Carvajal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Cavada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Gallardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Contreras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.T.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5936-3146","authenticated-orcid":false,"given":"P.","family":"Florenzano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,5]]},"reference":[{"key":"5875_CR1","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/jbmr.340","volume":"26","author":"TO Carpenter","year":"2011","unstructured":"Carpenter TO, Imel EA, Holm IA, Jan de Beur SM, Insogna KL (2011) A clinician's guide to X-linked hypophosphatemia. J Bone Miner Res 26:1381\u20131388","journal-title":"J Bone Miner Res"},{"key":"5875_CR2","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S2213-8587(19)30426-7","volume":"8","author":"P Florenzano","year":"2020","unstructured":"Florenzano P, Cipriani C, Roszko KL, Fukumoto S, Collins MT, Minisola S, Pepe J (2020) Approach to patients with hypophosphataemia. Lancet Diabetes Endocrinol 8:163\u2013174","journal-title":"Lancet Diabetes Endocrinol"},{"key":"5875_CR3","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1007\/s00198-018-4618-2","volume":"29","author":"G Marcucci","year":"2018","unstructured":"Marcucci G, Masi L, Ferrar\u00ec S, Haffner D, Javaid MK, Kamenick\u00fd P, Reginster JY, Rizzoli R, Brandi ML (2018) Phosphate wasting disorders in adults. Osteoporos Int 29:2369\u20132387","journal-title":"Osteoporos Int"},{"key":"5875_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00774-011-0340-2","volume":"30","author":"TO Carpenter","year":"2012","unstructured":"Carpenter TO (2012) The expanding family of hypophosphatemic syndromes. J Bone Miner Metab 30:1\u20139","journal-title":"J Bone Miner Metab"},{"key":"5875_CR5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1530\/EJE-15-0661","volume":"174","author":"H Che","year":"2016","unstructured":"Che H, Roux C, Etcheto A, Rothenbuhler A, Kamenicky P, Linglart A, Briot K (2016) Impaired quality of life in adults with X-linked hypophosphatemia and skeletal symptoms. Eur J Endocrinol 174:325\u2013333","journal-title":"Eur J Endocrinol"},{"key":"5875_CR6","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1210\/js.2018-00365","volume":"3","author":"A Skrinar","year":"2019","unstructured":"Skrinar A, Dvorak-Ewell M, Evins A, Macica C, Linglart A, Imel EA, Theodore-Oklota C, San Martin J (2019) The lifelong impact of X-linked hypophosphatemia: results from a burden of disease survey. J Endocr Soc 3:1321\u20131334","journal-title":"J Endocr Soc"},{"key":"5875_CR7","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1210\/jc.2003-030036","volume":"88","author":"O M\u00e4kitie","year":"2003","unstructured":"M\u00e4kitie O, Doria A, Kooh SW, Cole WG, Daneman A, Sochett E (2003) Early treatment improves growth and biochemical and radiographic outcome in X-linked hypophosphatemic rickets. J Clin Endocrinol Metab 88:3591\u20133597","journal-title":"J Clin Endocrinol Metab"},{"key":"5875_CR8","first-page":"A4874","volume":"61","author":"LH Nielsen","year":"2014","unstructured":"Nielsen LH, Rahbek ET, Beck-Nielsen SS, Christesen HT (2014) Treatment of hypophosphataemic rickets in children remains a challenge. Dan Med J 61:A4874","journal-title":"Dan Med J"},{"key":"5875_CR9","first-page":"839","volume":"76","author":"NE Friedman","year":"1993","unstructured":"Friedman NE, Lobaugh B, Drezner MK (1993) Effects of calcitriol and phosphorus therapy on the growth of patients with X-linked hypophosphatemia. J Clin Endocrinol Metab 76:839\u2013844","journal-title":"J Clin Endocrinol Metab"},{"key":"5875_CR10","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/jbmr.5650070602","volume":"7","author":"DJ Petersen","year":"1992","unstructured":"Petersen DJ, Boniface AM, Schranck FW, Rupich RC, Whyte MP (1992) X-linked hypophosphatemic rickets: a study (with literature review) of linear growth response to calcitriol and phosphate therapy. J Bone Miner Res 7:583\u2013597","journal-title":"J Bone Miner Res"},{"key":"5875_CR11","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1007\/s00198-017-3949-8","volume":"28","author":"GP Colares Neto","year":"2017","unstructured":"Colares Neto GP, Pereira RM, Alvarenga JC, Takayama L, Funari MF, Martin RM (2017) Evaluation of bone mineral density and microarchitectural parameters by DXA and HR-pQCT in 37 children and adults with X-linked hypophosphatemic rickets. Osteoporos Int 28:1685\u20131692","journal-title":"Osteoporos Int"},{"key":"5875_CR12","doi-asserted-by":"crossref","first-page":"S288","DOI":"10.1016\/j.bone.2011.03.744","volume":"48","author":"G Alonso","year":"2011","unstructured":"Author links open overlay panel, Alonso G, Plantalech L, Guelman R, Gonzalez S, Redal MA, Cassinelli H, Pasqualini T (2011) Familiar hypophosphatemic rickets: molecular findings in thirteen Argentinean families. Bone 48:S288\u2013S289","journal-title":"Bone"},{"key":"5875_CR13","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1210\/JC.2015-2199","volume":"100","author":"J Connor","year":"2015","unstructured":"Connor J, Olear EA, Insogna KL et al (2015) Conventional therapy in adults with X-linked hypophosphatemia: effects on enthesopathy and dental disease. J Clin Endocrinol Metab 100:3625\u20133632","journal-title":"J Clin Endocrinol Metab"},{"key":"5875_CR14","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1542\/peds.58.2.259","volume":"58","author":"GJ Schwartz","year":"1976","unstructured":"Schwartz GJ, Haycock GB, Edelmann CM, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259\u2013263","journal-title":"Pediatrics"},{"key":"5875_CR15","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.bone.2008.02.014","volume":"42","author":"I Endo","year":"2008","unstructured":"Endo I, Fukumoto S, Ozono K et al (2008) Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement. Bone 42:1235\u20131239","journal-title":"Bone"},{"key":"5875_CR16","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1210\/jcem.86.8.7761","volume":"86","author":"IA Holm","year":"2001","unstructured":"Holm IA, Nelson AE, Robinson BG, Mason RS, Marsh DJ, Cowell CT, Carpenter TO (2001) Mutational analysis and genotype-phenotype correlation of the PHEX gene in X-linked hypophosphatemic rickets. J Clin Endocrinol Metab 86:3889\u20133899","journal-title":"J Clin Endocrinol Metab"},{"key":"5875_CR17","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.bone.2019.01.021","volume":"121","author":"C Zhang","year":"2019","unstructured":"Zhang C, Zhao Z, Sun Y et al (2019) Clinical and genetic analysis in a large Chinese cohort of patients with X-linked hypophosphatemia. Bone 121:212\u2013220","journal-title":"Bone"},{"key":"5875_CR18","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1136\/ard.16.4.494","volume":"16","author":"JH Kellgren","year":"1957","unstructured":"Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16:494\u2013502","journal-title":"Ann Rheum Dis"},{"key":"5875_CR19","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1093\/tropej\/46.3.132","volume":"46","author":"TD Thacher","year":"2000","unstructured":"Thacher TD, Fischer PR, Pettifor JM, Lawson JO, Manaster BJ, Reading JC (2000) Radiographic scoring method for the assessment of the severity of nutritional rickets. J Trop Pediatr 46:132\u2013139","journal-title":"J Trop Pediatr"},{"key":"5875_CR20","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.bone.2019.02.010","volume":"122","author":"TD Thacher","year":"2019","unstructured":"Thacher TD, Pettifor JM, Tebben PJ, Creo AL, Skrinar A, Mao M, Chen CY, Chang T, San Martin J, Carpenter TO (2019) Rickets severity predicts clinical outcomes in children with X-linked hypophosphatemia: utility of the radiographic Rickets Severity Score. Bone 122:76\u201381","journal-title":"Bone"},{"key":"5875_CR21","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1210\/jc.2012-2747","volume":"98","author":"AM Boyce","year":"2013","unstructured":"Boyce AM, Shawker TH, Hill SC, Choyke PL, Hill MC, James R, Yovetich NA, Collins MT, Gafni RI (2013) Ultrasound is superior to computed tomography for assessment of medullary nephrocalcinosis in hypoparathyroidism. J Clin Endocrinol Metab 98:989\u2013994","journal-title":"J Clin Endocrinol Metab"},{"key":"5875_CR22","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.4067\/S0034-98872010000900006","volume":"138","author":"AR Osses","year":"2010","unstructured":"Osses AR, Yanez VJ, Barria PP, Palacios MS, Dreyse DJ, Diaz PO, Lisboa BC (2010) Reference values for the 6-minutes walking test in healthy subjects 20-80 years old. Rev Med Chil 138:1124\u20131130","journal-title":"Rev Med Chil"},{"key":"5875_CR23","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1056\/NEJMoa1714641","volume":"378","author":"TO Carpenter","year":"2018","unstructured":"Carpenter TO, Whyte MP, Imel EA et al (2018) Burosumab therapy in children with X-linked hypophosphatemia. N Engl J Med 378:1987\u20131998","journal-title":"N Engl J Med"},{"key":"5875_CR24","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/S0895-4356(98)00106-1","volume":"51","author":"B Gandek","year":"1998","unstructured":"Gandek B, Ware JE, Aaronson NK et al (1998) Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 51:1149\u20131158","journal-title":"J Clin Epidemiol"},{"key":"5875_CR25","unstructured":"Olivares P (2006) Estado de Salud de Beneficiarios del Sistema de Salud de Chile 2004-2005. Superintendencia de Isapres, Departamento de Estudios y Desarrollo"},{"key":"5875_CR26","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1016\/S0140-6736(19)30654-3","volume":"393","author":"EA Imel","year":"2019","unstructured":"Imel EA, Glorieux FH, Whyte MP et al (2019) Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial. Lancet 393:2416\u20132427","journal-title":"Lancet"},{"key":"5875_CR27","doi-asserted-by":"crossref","unstructured":"Seefried L, Smyth M, Keen R, Harvengt P (2020) Burden of disease associated with X-linked hypophosphataemia in adults: a systematic literature review. Osteoporos Int","DOI":"10.1007\/s00198-020-05548-0"},{"key":"5875_CR28","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1056\/NEJM199112263252604","volume":"325","author":"CF Verge","year":"1991","unstructured":"Verge CF, Lam A, Simpson JM, Cowell CT, Howard NJ, Silink M (1991) Effects of therapy in X-linked hypophosphatemic rickets. N Engl J Med 325:1843\u20131848","journal-title":"N Engl J Med"},{"key":"5875_CR29","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/S0022-3476(87)80245-7","volume":"111","author":"PR Goodyer","year":"1987","unstructured":"Goodyer PR, Kronick JB, Jequier S, Reade TM, Scriver CR (1987) Nephrocalcinosis and its relationship to treatment of hereditary rickets. J Pediatr 111:700\u2013704","journal-title":"J Pediatr"},{"key":"5875_CR30","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1136\/adc.65.10.1125","volume":"65","author":"GS Reusz","year":"1990","unstructured":"Reusz GS, Hoyer PF, Lucas M, Krohn HP, Ehrich JH, Brodehl J (1990) X linked hypophosphataemia: treatment, height gain, and nephrocalcinosis. Arch Dis Child 65:1125\u20131128","journal-title":"Arch Dis Child"},{"key":"5875_CR31","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1097\/00005792-198911000-00002","volume":"68","author":"IR Reid","year":"1989","unstructured":"Reid IR, Hardy DC, Murphy WA, Teitelbaum SL, Bergfeld MA, Whyte MP (1989) X-linked hypophosphatemia: a clinical, biochemical, and histopathologic assessment of morbidity in adults. Medicine (Baltimore) 68:336\u2013352","journal-title":"Medicine (Baltimore)"},{"key":"5875_CR32","first-page":"879","volume":"75","author":"W Sullivan","year":"1992","unstructured":"Sullivan W, Carpenter T, Glorieux F, Travers R, Insogna K (1992) A prospective trial of phosphate and 1,25-dihydroxyvitamin D3 therapy in symptomatic adults with X-linked hypophosphatemic rickets. J Clin Endocrinol Metab 75:879\u2013885","journal-title":"J Clin Endocrinol Metab"},{"key":"5875_CR33","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S0022-3476(81)80951-1","volume":"99","author":"H Rasmussen","year":"1981","unstructured":"Rasmussen H, Pechet M, Anast C, Mazur A, Gertner J, Broadus AE (1981) Long-term treatment of familial hypophosphatemic rickets with oral phosphate and 1 alpha-hydroxyvitamin D3. J Pediatr 99:16\u201325","journal-title":"J Pediatr"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-021-05875-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-021-05875-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-021-05875-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T05:25:24Z","timestamp":1671513924000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-021-05875-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,5]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["5875"],"URL":"https:\/\/doi.org\/10.1007\/s00198-021-05875-w","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,5]]},"assertion":[{"value":"13 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"PF, MJ, and DI have received Research Grant Support from Ultragenyx Pharmaceuticals. PF is an Advisory Board Member of Kyowa Kirin. MT Collins is supported by the Division of Intramural Research, National Institute of Dental and Craniofacial Research, NIH, Bethesda, MD. CAC is supported by Grants CONICYT-FONDECYT 1190250, IMII P09\/16-F (ICM-MINECON), and CETREN-UC. All other authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}